© 1992 Oxford University Press
research-article |
Risk Factors for Fatal Venous Thromboembolism in Young Women: A Case-Control Study

*Department of Public Health md Primary Care, University of Oxford Gibson Building, Radcliffe Infirmary, Oxford OX2 6HE, UK
Department of Human Nutrition, University of Otago PO Box 56, Dunedin, New Zealand
Thorogood M (Department of Public Health and Primary Care, University of Oxford, Gibson Building, Radcliffe Infirmary, Oxford, UK), Mann J, Murphy M and Vessey M. Risk factors for fatal venous thromboembolism in young women: A case-control study. International Journal of Epidemiology 1992; 21: 4852.
A case-control study of fatal venous thromboembolism in young women is described. Sixty women aged between 16 and 39 who died from thromboembolism in England and Wales between 1986 and 1988 were included in the study. Two living controls matched for age and marital status were sought from the records of the general practitioner with whom each case was registered. Some 115 controls were included in the study. The cases had a significantly higher prevalence of a history of major illness, particularly thrombotic episodes, than the controls. The odds ratio (OR) of a fatal thromboembolisrn in women who had a history of venous thrombosis was 4.0 (95% CI: 1.411.5). There was also a significantly higher frequency of a recent operation or accident amongst the cases than the controls (OR = 11.1, 95% CI: 1.392.5). There was no significant excess of oral contraceptive use amongst the cases. The overall OR associated with current use of oral contraceptives was 1.6(95% CI: 0.73.4), while the corresponding OR for idiopathic disease was 2.1(95% CI: 0.85.2). These risks are considerably smaller than those observed in previous studies. The observed risk may be low because the dosage of oestrogen in modern oral contraceptive preparations has been reduced, but it may also be because the cases of fatal venous thromboembolisen included in this study represent only a small propor tion of all cases of venous thromboembolism; a disease which is rarely fatal in young women. These results cannot necessarily be extrapolated to nonfatal venous thromboembolism.
Received 1 July 1991
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A van Hylckama Vlieg, F M Helmerhorst, J P Vandenbroucke, C J M Doggen, and F R Rosendaal The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study BMJ, August 13, 2009; 339(aug13_2): b2921 - b2921. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. R. Rosendaal Venous Thrombosis: The Role of Genes, Environment, and Behavior Hematology, January 1, 2005; 2005(1): 1 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. V. Gomes and S. R. Deitcher Risk of Venous Thromboembolic Disease Associated With Hormonal Contraceptives and Hormone Replacement Therapy: A Clinical Review Arch Intern Med, October 11, 2004; 164(18): 1965 - 1976. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Anderson Jr. and F. A. Spencer Risk Factors for Venous Thromboembolism Circulation, June 17, 2003; 107(90231): I-9 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.R. Rosendaal, F.M. Helmerhorst, and J.P. Vandenbroucke Female Hormones and Thrombosis Arterioscler Thromb Vasc Biol, February 1, 2002; 22(2): 201 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C Hannaford and V. Owen-Smith Using epidemiological data to guide clinical practice: review of studies on cardiovascular disease and use of combined oral contraceptives BMJ, March 28, 1998; 316(7136): 984 - 987. [Abstract] [Full Text] |
||||
![]() |
J. D. Douketis, J. S. Ginsberg, A. Holbrook, M. Crowther, E. K. Duku, and R. F. Burrows A Reevaluation of the Risk for Venous Thromboembolism With the Use of Oral Contraceptives and Hormone Replacement Therapy Arch Intern Med, July 28, 1997; 157(14): 1522 - 1530. [Abstract] [PDF] |
||||
![]() |
A. Cogo, E. Bernardi, P. Prandoni, B. Girolami, F. Noventa, P. Simioni, and A. Girolami Acquired Risk Factors for Deep-Vein Thrombosis in Symptomatic Outpatients Arch Intern Med, January 24, 1994; 154(2): 164 - 168. [Abstract] [PDF] |
||||




